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ABSTRACT 
 
DEVELOPMENT OF ARTIFICIAL CELL CULTURE PLATFORMS USING 
MICROFLUIDICS 
 
HANDE KARAMAHMUTOGLU 
Mechatronics Engineering, MSc, Thesis, July 2019 
Thesis Supervisor: Assoc. Prof. Dr. Meltem Elitas 
 
Key Words: Cell Culture, Cancer, Microfluidics, Lab-on-a-chip and Single-cell resolution.  
Acquiring quantitative data about cells, cell-cell interactions and cellular responses to 
surrounding environments are crucial for medical diagnostics, treatment and cell biology 
research. Nowadays, this is possible through microfluidic cell culture platforms. These 
devices, lab-on-a-chip (LOC), are capable of culturing cells with the feature of mimicking 
in vivo cellular conditions. Through the control of fluids in small volumes, LOC closely 
mimics the nature of cells in the tissues compared to conventional cell culturing platforms 
such as flasks and cell culture plates. On the other hand, existing LOC-based cell culturing 
platforms are highly complicated to be used in clinics or laboratories without an expert who 
develops these microfluidic platforms.  
Therefore, in this thesis we developed simple and user-friendly microfluidic cell culturing 
platforms and compared our obtained data with the conventional methods. We performed 
our research on different human cancer cell lines including liver hepatocellular carcinoma, 
breast adenocarcinoma, and lymphoma cell lines; both monocytes and monocyte-
differentiated macrophages. We examined proliferation rate, morphological and 
phenotypical differences of the cells in different scales. In addition to cell culturing 
platform, we developed a microfluidic gradient generator to precisely titrate the 
concentration of chemicals and observed cellular responses to these stresses. Moreover, we 
quantitatively inspected the effect of different intravenous fluids on different human cancer 
cell lines.  
Finally, we have developed simple, low-cost and integrable microfluidic platforms, those 
can be used by untrained people, and perform cell culture experiments in a population at 
single-cell resolution. Our microfluidic cell culture platforms provide more quantitative and 
qualitative data compared to traditional batch culture assays. 
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ÖZET 
 
MIKROAKISKALARIN KULLANIMI ILE YAPAY HÜCRE KÜLTÜRÜ 
PLATFORMLARININ GELISTIRILMESI 
 
HANDE KARAMAHMUTOĞLU 
Mekatronik Mühendisliği Yüksek Lisans Tezi, Temmuz 2019 
Tez danışmanı: Dr. Meltem Elitaş 
 
Anahtar Kelimeler: Hücre kültürü, Kanser, Mikro akışkanlar, Çip üstü laboratuvar ve Tek 
hücre çözünürlüğü  
 
Hücreler, hücre-hücre etkileşimleri ve hücrelerin etraflarını saran ortama verdikleri 
tepkilerle ilgili nicel bilgi elde etmek, medikal tanı, tedavi ve hücre biyolojisi araştırmaları 
için oldukça önemlidir. Günümüzde bu mikro akışkan hücre platformları aracılığıyla 
mümkündür. Bu cihazlar, çip-üstü-laboratuvar (ÇÜL), in vivo hücre koşullarını taklit etme 
özelliği ile hücre kültür etme uygulamaları için kullanılmaktadırlar. Sıvıların küçük 
hacimlerde kontrolü ile ÇÜL teknolojileri, kültür flask ve şişeleri gibi geleneksel hücre 
kültür platformlarına kıyasla dokulardaki hücrelerin doğasını yakın bir şekilde taklit ederler. 
Diğer taraftan var olan ÇÜL tabanlı hücre kültür platformları bu mikroakışkan platformları 
geliştiren bir uzman olmadan kliniklerde ve laboratuvarlarda kullanılmak için çok 
karmaşıktır. 
Dolayısıyla, bu tezde basit ve kullanıcı dostu mikro akışkan hücre kültür cihazları geliştirdik 
ve elde ettiğimiz verileri geleneksel metotlar ile kıyasladık. Araştırmamızı karaciğer 
hepatosellüler karsinom, göğüs adenokarsinom ve lenfoma hücre hatları, monosit ve 
monositlerden türetilmiş makrofajların ikisini de içeren farklı insan hücre hatları üzerinde 
gerçekleştirdik. Farklı ölçeklerde hücrelerin çoğalma oranı, morfolojik ve fenotipik 
farklılıklarını inceledik. Hücre kültür platformuna ek olarak kimyasalların 
konsantrasyonlarını tam olarak titre etmek için bir mikroakışkan gradyan üretici geliştirdik 
ve bu streslere verilen hücresel tepkileri gözlemledik. Bundan başka farklı intravenöz 
sıvıların farklı insan kanser hücre hatlarına olan etkisini nicel olarak inceledik.  
Son olarak, eğitilmemiş insanlar tarafından kullanılabilecek olan, basit, düşük maliyetli ve 
entegre edilebilir mikroakışkan platformlar geliştirdik ve bir popülasyonda tek hücre 
çözünürlüğünde hücre kültürü deneyleri yaptık. Bizim mikroakışkan hücre kültürü 
platformlarımız konvansiyonel yöntemlerle yapılan hücre kültürü deneylerine göre daha 
nicel ve niteliksel veri sağlıyor. 
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“Do you know what’s one mistake we always make? Believing that life’s immutable, 
that once you get on a particular track you have to follow it to the end of the line. But it 
appears that fate has more imagination than we do. Just when you think you’re in a 
situation you can’t escape from, when you’ve reached the lowest depts of total 
desperation, everything changes as fast as a gust of wind, everything’s overturned; from 
one second to the next you find you’re living a new life.” 
-Susanna Tamaro 
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Chapter 1 
 
INTRODUCTION 
 
1.1 Motivation 
Cell culture in vitro is essential, for both understanding of cell biology and medical 
diagnosis and treatment [1]. Through the investigation of cellular behavior in a controlled 
in vitro environment, providing proper media and gas along with appropriate temperature 
for cell growth and reproduction, experiments can be done with reduced cost and labor in 
comparison to tissue culture and animal experiments [2]. Thus, for establishing this 
controlled environment several cell culturing platforms are being used including 
macroscopic polystyrene dishes, flasks or wells. However, petri dishes and well plates as 
traditional cell culturing platforms are limited to cell analysis on a population level [3]. 
Recent studies showed alteration in cell behavior even if cells are identical and in the 
same microenvironment [4]. Therefore, there is a need to examine large number of cells 
on a single-cell resolution in a microfluidic environment to have a better insight in cellular 
function. Conventional cell culturing tools are not adequate for this purpose. To establish 
a controlled microenvironment and to be able to perform single-cell level analysis, 2D 
microfluidic cell culturing platforms have been introduced and used [5].  
 
 
 
2 
 
Quantification and accuracy of analyzed data from these platforms are also very 
important [6]. Therefore, for the microfluidic cell culturing platforms, 
Polydimethylsiloxane (PDMS), an optically transparent material used for molding that is 
nontoxic, biocompatible, gas permeable and, thermally and chemically stable, is preferred 
to obtain data with microscopy imaging from microfluidic chips [7]. Moreover, PDMS 
based microfluidic chips for cell culture allows researchers to analyze cells as individuals 
and as cell populations at single-cell resolution depending on their chip designs and 
experimental protocols [8]. Nevertheless, these platforms are mostly too complex and not 
adaptable for different applications. Also, 2-dimensional (2D) cell culture platforms are 
not representative of real cell environment. In this manner, 3-dimensional (3D) cell 
cultures, introduced by Ross Granville Harrison with the hanging drop method from 
bacteriology to carry out the first tissue culture increased the interest in 3D cell cultures 
started to rise due to their potential in drug development since they are considered more 
realistic compared to 2D cell culturing platforms [9]. Still, most of the 3D culture 
technologies are costly, bulky and require too much time and effort, therefore, they are 
still at their crawling period for drug development screening and research. Furthermore, 
compared to 2D cell culture platforms, imaging and analysis is harder due to their 
complexity. On the other hand, 2D cell culture systems are less expensive than most 
systems and they are easier to analyze [10].  
As a result, 2D microfluidic cell culturing platforms are preferred more for cell 
biology research today. They provide laminar flow and large surface-to area-to-volume 
(SAV) ratio. Various aspects of the cellular microenvironment could be engineered in a 
precisely controlled manner, creating a cell microenvironment in a controllable and 
reproducible fashion to test biological questions [11]. 
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1.2 Contributions of the Thesis 
 
This thesis aims to create and test alternative cell culturing platforms that are 
adaptable, simple and integrable for different purposes including cell analysis in single-
cell resolution and under different microenvironments. We propose two microfluidic 
platforms; one of them aims cell culturing and second one generates gradients of drugs. 
In these artificial devices breast cancer cells were grown. Then, culturing platforms were 
connected to a microfluidic gradient generator. Next. Sodium dodecyl sulfate (SDS), as a 
drug representative, was flown through the gradient chip, supplying different gradients of 
SDS to the microfluidic chip with grown cells to mimic drug effect.  Thus, a microfluidic 
cell culturing platform and a microfluidic gradient generator was established for the 
investigation of drug concentration in personalize medicine in vitro allowing cell culturing 
in flow, live cell imaging and high-throughput analysis. Then, new chip designs were 
developed for investigating cell behavior and morphology using cancer and immune 
system cell lines. This thesis presents novel cell culturing platforms to culture cells for 
personalized medicine, medical diagnostics and cell biology research. 
 
 
1.3 Thesis Outline 
 
Chapter 2 presents the literature survey about cellular microenvironment, batch 
culture and microfluidic cell culture platforms. Chapter 3 introduces artificial cell 
culturing platforms, experimental procedures and illustrates setups for cell loading and 
culturing. Preparation of cells, fabrication of microfluidic devices and image acquisition 
techniques are also explained. In Chapter 4, the results of experiments in conventional 
culturing devices and in artificial cell culturing platforms are demonstrated along with 
discussions. Finally, thesis is concluded in Chapter 5 with possible future applications 
of microfluidic cell culturing platforms. 
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1.4 Publications 
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• Karamahmutoglu H, Altay A, Ozkazanc D, Elitas M. (2018) “Quantitative 
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Chapter 2 
 
BACKGROUND/THEORY 
 
Microenvironment of a cell is created by factors that directly determine conditions 
around a cell or a group of cells, such as; cells, interstitial fluid and extracellular matrix 
(ECM) including tissue-specific proteins and polysaccharides [12] [13] [14]. They 
physically, mechanically and biomechanically affect cellular phenotype [15]. Also, they 
can considerably alter cell behavior and fate by manipulating microenvironmental 
features [16] [17]. For instance, Satyam et al. demonstrated that with macromolecular 
crowding in the cell microenvironment the secretion of ECM molecules could be 
developed for corneal fibroblasts [18]. The changes in the microenvironment of cells 
influence cell proliferation as well.  Generation of new cells is important since it is 
essential for tissue growth and propagation and is considered as one of the hallmarks of 
cancer (Figure 2.1) [19] [20].  
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Figure 2.1. The hallmarks of cancer [20]. 
 
 
Surgery, chemotherapy, and radiotherapy have been the most common cancer 
treatment methods for a long time [21]. These conventional cancer therapies have been 
considerably beneficial in the elimination of primary tumors. Nevertheless, there is a 
cancer recurrence issue due to tumor metastases [22]. Furthermore, the number of new 
cancer cases has become approximately 18.1 million and almost 9.6 million people lost 
their life due to cancer in 2018 [23]. Thus, new cancer therapies for the eradication of 
tumor cells have been investigated [24]. Latest research has revealed multiple functions 
of the tumor microenvironment (TME) in the adjustment of therapeutic efficacy. Even 
though the effect TME activities have on cancer initiation and metastasis are well known, 
our insight of the TME's impact on treatment results is still inadequate [25]. Hence, the 
trend in cancer research has changed from the examination of fatal cancer cells themselves 
to the investigation of tumor microenvironment and the interactions within [26].  
TME consists of resident fibroblasts, endothelial cells, pericytes, leukocytes and 
extracellular matrix, and causes to the progression of cancer (Figure 2.2.) [27].  It is well 
established that non-tumor cells are genetically more balanced compared to tumor cells 
[26] [28]. Therefore, treatments targeting the TME have a very low possibility for 
generating adaptive mutations and fast metastasis. Still, since cells can both initiate and 
prevent tumor cell growth, treatments targeting the TME for cancer therapy should be 
discriminative [26]. Recently, for the investigation of TME, in vitro cell culturing 
techniques are being preferred preliminary for in vivo experiments. This is partly because 
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in vivo tests are very costly and ethical problems due to animal testing [29] [30] [31]. 
Thus, studies with in vitro cell culture models has gained a growing attention [32].  
 
 
Figure 2.2. Detailed illustration of the tumor microenvironment showing representative 
cell types, tissues, and signaling factors involved [27]. 
 
 
Conventional cell culture platforms are macroscopic polystyrene dishes, flasks or 
wells [3]. Using these vessels and novel microfluidic platforms, cells can be cultured in 
vitro. However, researchers accepted failure in reproducibility of their own assays using 
batch culture and microfluidic cell culture [7] [33]. Different outcomes were obtained 
after repeating an assay in the same way it was performed before because of the changes 
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within the cell environment [34]. This inconsistency in conventional and microfluidic 
platforms is a solvable problem using the right tools [35]. Additionally, in conventional 
cell culturing platforms cells remain in static condition, yet this is not the case for cells 
inside human body. This means that the dynamic physiological conditions for cells 
cannot be monitored in conventional cell culturing vessels with gradients of 
temperature and CO2 concentrations that are not optimal [36]. Therefore, it is important 
to provide sensitive cell culture platforms in which cellular microenvironment can be 
controlled allowing cell analysis.  
Novel in vitro cell culturing platforms assists in the examination of various 
culturing properties that have been investigated with conventional culturing platforms for 
centuries such as cell proliferation to show drug efficacy in stopping tumor cell 
proliferation [37]. Investigation of cell proliferation with the likelihood of metastases lead 
to a better understanding of the influence that culturing elements have on tumor 
progression [26]. These platforms are microfluidic cell culturing platforms. They allow 
the manipulation of spatial and temporal gradients and patterns that cannot be obtained 
and controlled in conventional platforms (Figure 2.3) [38]. Compared to traditional batch 
culture, microfluidic devices require smaller volumes of materials and thus shorter 
experiment time due to parallelization and lower cost of assays 
[39], [40], [41]. Microfluidic cell culture is also proficient for advancing precision 
medicine focused studies [42]. These works have generated a significant effect on 
knowledge about cellular activities that is essential in regulating disease features and 
responses to stimuli [43] [44] [45]. 
Figure 2.3. Microenvironmental parameters for cell culture [38]. 
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In last decades, through the culturing of cells inside novel microfluidic devices a 
better insight about the cellular microenvironment was obtained and these platforms were 
used for various purposes. With the control of the mitotic mechanisms by trapping cells 
inside a microfluidic platform, it was discovered that the behavior of HeLa cells altered 
substantially during mitosis due to the entrapment of cells (Figure 2.4). Additionally, 
researchers observed that new cells produced after the entrapment had different sizes from 
each other [46] [47]. For trapping nonadherent cells, another microfluidic chip was 
fabricated in which the immunostaining and labeling of THP-1 cell membranes was 
shown. This platform allowed cells to be captured without the need for centrifuging and 
resuspension [48]. In another study, miniaturized fiber-based optical tweezers were used 
in integration with microfluidic chip for single-cell trapping using red blood cells and 
colon cancer cells (Figure 2.5). Researchers were able to obtain fluorescence and Raman 
measurements of single cells [49]. 
Figure 2.4. The effect of microlevel trapping on the division of HeLa cells. (a) The 
macroscopic structure of the microfluidic PDMS platform. (b) The cross-section of the 
microfluidic PDMS platform posts. With the utilization of pressure on the posts, cells can 
be trapped within the area between the posts. (The distance between the posts is 40 μm). 
(c) The trapping generated substantial shifts in the behavior of the cells during mitosis and 
led to the production of new cells with different sizes [46].  
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Figure 2.5. Optical micro-tweezer integrated in a microfluidic chip. (a) Isometric view of 
the optical tweezers integrated in the microfluidic system (b) Top view picture of the 
device. (c) Enlarged picture of the optical tweezers inside the microfluidic channel (d) 
Enlarged view of the microprisms on the optical tweezers [49]. 
  
 
There are various microfluidic platforms fabricated for single-cell investigations. 
For example, Ono et al. developed a single-cell and feeder-free culture system for primate 
pluripotent stem cells. Researchers suggested that monkey embryonic cells cultured in 
this system can be used for in vitro differentiation and gene manipulation [50]. There are 
various other culturing platforms designed for singe-cell analysis in which cells are 
isolated, trapped and manipulated in several ways. These isolation and capture methods 
include droplet-based microfluidics, hydrodynamics, magnetic forces, acoustics, optics 
and dielectrophoretic traps (Figure 2.6) [51].  For instance, scientists used a droplet-based 
microfluidic device to separate cells to examine cell growth in a monodisperse nanoliter 
aqueous droplets surrounded by an immiscible fluorinated oil phase (Figure 2.7). Thus, 
they were able to obtain high throughput using Saccharomyces cerevisiae cells for gene 
identification [52]. 
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Figure 2.6. Schematic demonstrating various approaches for cell isolation, capture and 
control of single cells in a microfluidic device [51]. 
 
 
Figure 2.7. Microfluidic high-throughput screening platform. Droplets are obtained 
through the combination of aqueous stream with two streams including a fluorinated oil 
and surfactant mixture [52]. 
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 Detection of biomarkers is another important application of microfluidic devices. 
For the detection of biomarkers multiple platforms have been used and tested [53] [54]. 
Moreover, microfluidic platforms have been used for personalized medicine through drug 
screening and discovery as well [55] [56]. Figure 2.8 demonstrates a microfluidic chip 
developed for monitoring of drug screening and cancer research. Scientists used T98G 
human brain cancer cells inside the microfluidic cell culture platform to investigate cancer 
cell metabolism [57]. There are a lot of other microfluidic culturing devices used with 
tumor cells [58] [59], stem cells [60] [61] and other cell types as well [62] [63] [64]. 
 
Figure 2.8. A microfluidic chip for monitoring drug screening and cancer research [57]. 
 
 
The cell culture platforms that are mentioned above are mostly 2D cell culturing 
platforms with short construction time, mimicking the in vivo environment. Still, recently 
some researchers started to suggest the use of 3D cell culturing devices [65]. In 2D 
microfluidic cell culturing platforms, cell growth occurs on flat surfaces. Cells attach to 
surface, then start spreading. With 2D culturing chips, cell behaviors can be examined 
through inexpensive and transparent materials. Also, these systems are expected 
worldwide. Still these devices have limitations about mimicking culture environment. 
Because, in vivo environment includes cells surrounded by other cells and extracellular 
matrix (ECM) and 2D cell culture is not enough in mimicking this whole 3D environment. 
Therefore, cell growth, spreading and migration based research can give misleading 
results. Yet mostly 2D cell culture outcomes supplies suitable data with in vivo studies 
[66] [38]. 
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Like 2D, establishing a 3D cell culture platform is a rapid process and the 
homeostasis compatibility of the 3D device with cells provides long-term stability [67]. 
Nevertheless, despite all advantages 3D culture techniques offer, there are technical 
problems in microscopy imaging of these devices. Compared to 2D structures, in 3D 
cultures there can be cases in which live cells cannot be visualized with bright field and 
phase microscopy. This is because bright field and phase microscopy depends on light 
transmission through the sample and in 3D cultures the samples may be simply too thick 
for light passage [68]. Therefore, alternative imaging techniques are required and being 
developed for 3D cultures. In addition to low throughput in cell imaging in 3D models 
there is difficulty in maneuverability [69]. Also, due to inconsistencies in between 
biologically derived matrices, assay outcomes may not be reproducible in 3D culture 
which is an issue for 2D culture as well [70]. In some 3D constructs, spheroids that differ 
highly in size are formed, leading to diversity within the same well/flask which is a 
disadvantage lowering the accuracy of an assay [71]. Another important weakness of 3D 
culture is that, vasculature, crucial for tumor growth/survival and drug delivery, is 
deficient in 3D models [72] [73]. Furthermore, 3D cultures are more costly for performing 
high throughput experiments in comparison to conventional 2D culture [71]. Hence, 2D 
microfluidic cultures are still being used often. Even though 3D systems are better for 
mimicking in-vivo organisms, they are very complicated while 2D microfluidic devices 
are simple and acknowledged by a bigger scientific community. 
Figure 2.9  Schematic of different cell culture models: Static 2D or 3D cell culture 
models, 2D microfluidic culture models, 3D microfluidic culture models [38]. 
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Chapter 3 
 
MATERIALS AND METHODS 
 
3.1 Design, simulation and fabrication of microfluidic chip 
 
Microfluidic chips in Figures 3.1 and 3.2 were designed with Layout Editor® and 
chips in Figures 3.3 and 3.4 were drawn with CleWin Layout Editor®. The microfluidic 
cell culture chip in Figure 3.1 consists of six identical cell culturing platforms that are 
independent of each other. These platforms were constructed as flexible designs that can 
be used for various cell lines. Also, these culturing chambers can be utilized with same 
type of cells given chemical titration through the microfluidic gradient generator chip in 
Figure 3.2. The butterfly shaped structures in Figure 3.1 represents pillars and they were 
placed in order to prevent polydimethylsiloxane (PDMS) collapse. These V-shaped pillars 
were created with smaller flow passages compared to the diameter of cells. This was done 
to hold the cells on these designs and to enclose the cells inside the chamber once they 
enter to the chamber. The bottom of the butterfly structure has passages to prevent the cell 
movement to outlets as well. Thus, when cells gather at the bottom of the V-shaped pillars, 
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the flow in the center of the culturing chamber is prevented. As a result, the system pushes 
surplus cells towards the outlet channel of the chamber. 
All culturing platforms on the microfluidic chip in Figure 3.1 consists of a single 
inlet and a single outlet connected through a channel with a microchamber in between in 
which cells loaded to the platforms can be grown and observed under microscopy. The 
diameters of inlet and outlets are 1 mm, the width of the inlet connection channel is 100 
μm and the width of the outlet connection channel decreases in width bit by bit to 50 μm. 
The main culturing chamber in each platform has 530 μm length and 444 μm width 
(Figure 3.1.b). The minimum gap between the pillars is 10 μm. 
Figure 3.1: Design of the microfluidic cell culture chip in Layout Editor®. (a) Cell culture 
platforms on a single chip with inlet (gray circles) and outlet (blue circles) diameters as 1 
mm, inlet connection channels gradually decreasing in width to 50 μm. Outlet connection 
channels are 100 μm wide. (b) Magnified view of the microchambers. (c) The white 
butterfly shaped pillars with 90 μm width to eliminate PDMS collapse [74]. 
Figure 3.2: The design of the microfluidic gradient generator device in Layout Editor®. 
a) The complete device with two inlets (blue circles) and six outlets (gray) with 1 mm 
diameter. b) Magnified view of mixing channels demonstrating the length and width of 
mixing channels [74]. 
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Figure 3.3: Design of the microfluidic cell culturing chip with dimensions. Inlet, outlets 
and cell loading hole are demonstrated with blue circles. White circles represent pillar 
structures [75]. 
 
Figure 3.4: Design of the microfluidic co-culture chip with 3 cell culturing platforms. 
Each platform consists of two inlets (red circles), outlets (blue circles) and cell loading 
points (green circles). White structures in the design were placed as pillar representatives.  
 
 
The design for the chemical gradient generator in Figure 3.2, was created based 
on the “Christmas tree” design, which is a famous design due to its accurate concentration 
dosing and gradient generation [76]. The gradient generator has two different inlets (blue 
circles) for obtaining gradients of chemical concentrations from six outlets (gray) with 
distribution rates of  0 %, 20 %, 40 %, 60 %, 80 % and 100 % (Fig. 3.2.a). With connection 
to microfluidic cell culturing platforms in Figure 3.1 through tubings the gradient 
generator was designed to be used for supplying different concentrations of a chemical as 
a drug representative to an adherent cell line for drug efficacy investigation. Thanks to 
microchannels being longer than their width, the gradients of the chemical produced 
 
 
 
17 
 
inside the chip are combined well and the chemical concentrations remain stable before 
being introduced to the cell culturing chip in Figure 3.1 [77, 78, 79, 80]. The diameter of 
channels is 60 μm in the whole chip to avoid possible inconsistencies in the velocity of 
the flow inside the chip. Like “Christmas tree” design, every flow given from the inlet 
divides into two streams, and these two streams join and create an average concentration 
of both streams. The inlet and outlet diameter of the chip is 1 mm.  
The chip design in Figure 3.3 was created as an alternative culturing chip for 
adherent cell lines. It has a cell loading hole (blue circle) apart from media inlet and outlets 
(blue circles) (Fig.3.3). In this chip design, media inlet and outlets were separated from 
cell loading point in order to avoid bubble problems while loading cells prior to 
experiments. Upon loading, the flow guides cells towards the media outlet and inlet holes. 
With pillars that were placed to avoid polymer collapse due to surface tension, cells are 
trapped inside the rectangular chambers. This way, while some cells leave the outlet, the 
majority of the cells are trapped inside culturing chambers for population level single cell 
resolution analysis. The rectangular cell growing chambers were arranged to be smaller 
in size towards the middle chamber in order to increase the number of trapped cells.  
The biggest rectangular culturing chamber in the microfluidic chip has 3500 µm 
width and 5200 µm length. Remaining two rectangles have 2400 µm and 1300 µm width 
and 1300 and 600 µm length from big to small, respectively. The chamber in between the 
inlet and outlet channels has 500 µm width and 1300 µm length. The inlet and outlet 
channel widths were kept the same in this design as 200 µm. Pillars (white circles) were 
inserted all over the chip design to prevent PDMS collapse (Fig. 3.3). 
For investigating the interactions between different cell lines purposes, the design 
in Figure 3.4 was created. This coculture chip consists of three identical cell culturing 
platforms that are independent from each other. Each of these platforms have two media 
inlets, outlets and cell loading holes for the investigation of different cell lines interactions 
with each other (Fig. 3.4). Through the inlets of a platform different cell types (diseased 
(cancer) and healthy (immune system)) can be loaded. Hence, two cell lines can be grown 
together. The geometry of the cell culturing microchambers includes two identical 
triangles with a rectangle in the middle. This way, upon loading of different cell types 
from two cell loading points, they will be mixed equally inside the microchamber. The 
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length of outlet channels is relatively longer then the length of the inlet channels in order 
to provide high flow resistance and prevent cell flow. Also, pillars (white circles) were 
placed inside the cell culture chamber to avoid PDMS collapse due to surface forces (Fig. 
3.4.). 
The edges of the isosceles triangles in the coculture chip design have 650 µm 
length (Fig. 3.4.). The rectangular culturing chamber in between the triangles have 1040 
µm width and 2299 µm length. The width of the inlet channels is 87 µm, the outlet 
channels is 100 µm, 50 µm and 10 µm in order decreasing towards the outlet to prevent 
cell escape. The pillar diameter is 115 µm and the distance between pillars is 150 µm. 
When the designs of the chips were completed, simulation and fabrication 
procedures were performed. All chip flow field and velocity distribution simulations in 
Figures 3.5 and 3.6 were achieved via COMSOL Multiphysics software version 5.1. 
Simulations in 3.9 and 3.10 were obtained in COMSOL Multiphysics software version 
5.3. The flow field simulations were performed to visualize cell passages inside the cell 
culturing chambers. Velocity distribution was simulated to establish minimum shear 
stress in the places where cells are trapped. For the chips in Figures 3.5, 3.7 and 3.9, the 
flow fields inside the platforms were estimated with the Navier-Stokes and Fick’s law 
equations, predefined in COMSOL platform. Stationary, single-phase, incompressible 
laminar flow was chosen for each simulation condition. In solid walls the flow field and 
initial values were set as 0 m/s and 0 mol/m3 in all directions. Non-slip and no flux 
conditions were defined for cell culturing chambers. The volumetric flow rate was set to 
10 µL/hr in the inlets of culturing platforms and the outlet pressure was defined as 0 Pa 
for all chip designs. The fluid chosen as the representative of media was water, with a 
density of (ρ) of 103 kg/m3 and dynamic viscosity (μ) of 8.9 x 10−4 N.s/m2. The inlets and 
the outlets of the flow were identified.  
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Figure 3.5. Simulation of the cell culturing platforms in Figure 3.1. a) Flow field of micro-
chamber designs. Red lines represent the streamlines of the flow. b) Velocity distribution 
simulation for the chambers. The distribution of the velocity is shown using rainbow 
colors, red illustrating high velocity and blue low velocity (mm/s). 
 
Figure 3.6 a) Pressure (Pa) and b) chemical concentration (mol/m3) simulations depicting 
uniform distribution through rainbow colors in the microfluidic gradient generator.  
 
Apart from other chip simulations, in the simulation of the gradient generator 
depicted in Figure 3.6, the inlet pressure was set to 10 kPa, and the chemical 
concentrations were defined as 0 mol/m3 for inlets. The outlet boundary condition was set 
as zero static pressure and outflow. The chemical concentrations and the pressure of the 
gradient generator were simulated using convection and diffusion equations. Rainbow 
colors were used to show a uniform flow distribution was established in all channels. 
Thus, diluted chemical concentrations were obtained from the outlets as 0, 0.2, 0.4, 0.6, 
0.8 and 1 (mole/m3) (Fig 3.6).  
 
a) b) 
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For the simulations of the microfluidic cell culturing chip in Figure 3.9 and the 
co-culturing platform in Figure 3.10, the designs were first established in three 
dimensions in Solidworks 2015 edition. Next, the Solidworks three dimensional designs 
in Figures 3.7 and 3.8 were transferred to COMSOL Multiphysics software version 5.3, 
where, the simulations were obtained for velocity and pressure distributions. 
 
Figure 3.7. The design of the microfluidic cell culture chip in Solidworks. The 
dimensions in the design are a: 3500 µm b: 5200 µm, c: 1300 µm, d: 600 µm, e: 4500 
µm, f: 1300 µm, g: 300 µm, h: µm, i:  350  µm, j: 330µm, k: 90 µm, l: 90 µm, m: 140 
µm, n: 240 µm, o: 200 µm . White circles in the design represent pillar structure (A: 
Medium Outlet, B: Medium Inlet and C: Cell loading point). 
 
Figure 3.8. The Solidworks design of the co-culture chip. The dimensions in the design 
are a: 1040 µm b: 2299 µm, c: 115 µm, d: 650 µm, e: 150 µm, f: 250 µm, g: 100 µm, h: 
50 µm, i: 10 µm, j: 100 µm. White circles in the design represent pillar structures. 
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Figure 3.9. Simulation of the cell culturing platforms. a) Velocity distribution simulation 
for the chambers (x 105 µm/s). b) Pressure distribution simulation for the chambers (x 
103 Pa). The distributions are shown using rainbow colors, red illustrating high velocity, 
pressure and blue low velocity, pressure.  
Figure 3.10. The a) velocity (µm/s) and b) pressure (Pa) simulations for the co-culture 
chip.  
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When the simulation results confirmed for the designed chips, their fabrication 
was performed. The mask designs were patterned on a thin film chromium deposited 
photo mask (Cr-blank) using a Vistec/ EBPG5000plusES Electron Beam Lithography 
system. For the chips in Figures 3.1 and 3.2, SU-8 2025(SU-8®2025, MicroChem) was 
spin coated on a 4-inches silicon wafer to obtain structures of height 40 μm. Next, the 
photoresist-coated wafers were soft baked at 65°C for 3 minutes and at 95°C for 5 
minutes. For the platforms in Figures 3.3 and 3.4, SU-8 3050 (SU-8® 3050, MicroChem) 
was spin coated on a 4-inches silicon wafer to obtain structures of height 50 μm. 
Afterwards, all wafers were exposed to UV light 160 mJ/cm-2 using e-beam written masks 
by a Midas/MDA-60MS mask aligner. After two consecutive post-baking process at 65°C 
for 1 min and at 95°C for 5 min, they were developed for 5 min using MicroChem’s SU-
8 developer. Later they were rinsed with isopropanol. The obtained wafers were used as 
molds for the elastomeric polymer, Polydimethylsiloxane, PDMS (Sylgard® 184, Dow 
Corning, Midland, MI, USA) [81]. The PDMS base and curing reagents were mixed at a 
ratio of 10:1. Then, the mixture was poured to the wafer. Upon bubble removal through 
vacuuming, the wafer with PDMS was baked at 75°C for 60 min. Finally, PDMS mold of 
the structures was removed. Chip designs were cut, and device inlet and outlet ports were 
punched. PDMS chips were bonded on glass slides utilizing the Corona system (BD20-
AC, Electro-Technic Products Inc.) [82]. 
                                                                    
3.2 Cell Culture and staining using conventional methods 
 
For different applications, various types of human cancer cell lines were cultured both 
using tissue culture techniques and microfluidic cell culturing platforms. All cells were 
kept inside a 5 % CO2 – 95 % air atmosphere in a humidified incubator (Nuve, Ankara, 
Turkey). Cell counting during culturing and experiments were performed using the 
Trypan blue dye (Sigma-Aldrich) with a hemocytometer (Marienfeld-Superior, Lauda-
Knigshofen, Germany). The following cell lines have been cultured according to ATCC 
(LGG Standards, Middlesex, UK) protocols: 
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• U937 monocytes (the human myeloid leukemia) cell line 
(ATCC®CRL-1593.2™) 
 
Monocytes were obtained from ATCC (American Type Culture Collection, 
Manassas, VA, USA). For culturing U937 monocytes, RPMI-1640 complete medium 
(PAN-Biotech, Aidenbach, Germany) supplemented with 10% fetal bovine serum (FBS; 
PAN-Biotech, Aidenbach, Germany) and 1% Penicillin-Streptomycin solution (PAN-
Biotech, Aidenbach, Germany) was used. Before each experiment, cells were spun down 
at 3000 rpm (MERCK, Darmstadt, Germany) for 5 minutes and resuspended in fresh 
media or appropriate intravenous fluid (IVF) according to experiment purpose. 
 
• U937 macrophages 
 
Macrophages were prepared by the differentiation of the U937 monocytes (5 x 105 
cells/mL) were seeded in a petri dish with complete medium including 2.5 µL of 10 ng/mL 
phorbol myristate acetate (PMA)/DMSO (PAN-Biotech, Aidenbach, Germany) solution 
for 5 days. In day 3 and 4, nonattached cells were removed by aspiration, and the adherent 
cells were washed with a complete medium. In day 5, after aspiration of the nonattached 
cells, differentiated macrophages were washed first with PBS (PAN-Biotech, Aidenbach, 
Germany) and then incubated for 10 minutes inside 1 mL pre-warmed trypsin solution 
(PAN-Biotech, Aidenbach, Germany). Detached macrophages were spun down at 3000 
rpm for 5 minutes to remove residual media.  Finally, cells were resuspended in fresh 
media or appropriate intravenous fluid (IVF) according to experiment purpose.  
 
• MCF7 human breast adenocarcinoma cell line (ATCC® HTB-22™) 
 
For the creation of RFP-expressing MCF7 (MCF7-RFP) cells, lentiviruses were 
produced by the transfection of pRSI9-U6-UbiC-TagRFP-2A-Puro plasmid (Addgene 
plasmid no. 28289) together with its helper plasmids psPAX2 and pMD2.G (Addgene 
plasmids 12260 and 12259) into HEK293T cells. Supernatants of cells were harvested 
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after 48 hours and 72 hours upon the transfection. The mixtures of collected supernatants 
were stored at −80 °C and used to infect the cells. MCF7 cells were infected at a 60 % 
confluence for 24 hours with lentiviral supernatants diluted 1:1 with full Dulbecco's 
modified Eagles' medium (DMEM; Sigma-Aldrich) culture medium supplemented with 
5 μg mL−1 polybrene (Sigma-Aldrich, H9268). Twenty-four hours after infection, the 
medium was altered with fresh medium. MCF7 cells expressing RFP vector were chosen 
with 1 μg mL−1 puromycin in DMEM supplemented with 10 % fetal bovine serum (FBS; 
Sigma-Aldrich), 1 % penicillin–streptomycin (Pen/Strep; Sigma-Aldrich) and 1 % L-
glutamine (Sigma-Aldrich) for a month. No additional stain was used. 
MCF7 cells expressing RFP vector were taken from Sabanci University Molecular 
Biology, Genetics and Bioengineering Department. MCF7-RFP cells were cultured in 
DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% L-glutamine both in 75 cm2 
flasks (Corning® T-75 flasks) and in the microfluidic platforms inside the incubator. 
Trypsin-EDTA (Sigma-Aldrich) solution was used to detach the cells from the flask and 
to load those cells into the microfluidic chips. Cells were cultured inside 96-well plates 
prior to loading inside the chips until their cell counts reached 3.5 x 104 cells/mL. 
 
• HepG2 human liver hepatocellular carcinoma epithelial cell line (ATCC®HB-
8065™) 
 
HepG2 cells were taken from Gebze Technical University Molecular Biology and 
Genetics department, were used to demonstrate the utility of the microfluidic cell culture 
platform. For culturing cells, DMEM (PAN-Biotech) supplemented with 10 % FBS 
(Sigma-Aldrich) was used both in 75cm2-flasks (Corning® T-75 flasks) and in the 
microfluidic chips inside the incubator. Trypsin-EDTA solution (Sigma-Aldrich) was 
used to detach the cells from the flask and to load those cells into the microfluidic chips. 
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• U87 human brain glioblastoma epithelial cell line (ATCC® HTB-14™) 
 
U87 cells were taken from Yeditepe University Molecular Biology and Genetics 
department, were used to demonstrate the utility of the microfluidic cell culture platform. 
For culturing cells, DMEM (PAN-Biotech) supplemented with 10 % FBS (Sigma-
Aldrich) was used both in 75cm2-flasks (Corning® T-75 flasks) and in the microfluidic 
chips inside the incubator. Trypsin-EDTA solution (Sigma-Aldrich) was used to detach 
the cells from the flask and to load those cells into the microfluidic chips. 
In experiments with intravenous fluids, U937 monocytes, macrophages and MCF7 
and HepG2 cells were stained separately with 0.128 mM Hoechst (Life Technologies) 
and 0.0111 mM Propodium Iodide (PI) (Sigma Aldrich) solutions for end-point staining. 
Cells were kept in solutions for 20 minutes in the incubator using 1 µL of dyes from the 
working solutions of Hoechst (10 mg/L in water) and Propidium Iodide (1 mg/L in water). 
Inside the microfluidic chips, for the heterogeneity analysis of the HepG2 cells no 
stain was used. For co-culturing purposes, U87 cells with red cell tracker (1 µM) and 
U937 macrophages were stained with green cell tracker (2 µM) inside 6-well plates.  
After cells were grown inside conventional cell culturing platforms, prior to loading 
the cells into the microfluidic devices we cleaned and prepared the chips. The cell 
culturing chip and the gradient generator in Figures 3.12 and 3.13 were cleaned using 70 
% aqueous ethanol. Next, the devices were washed in phosphate buffered saline (PBS; 
Sigma-Aldrich) in order to remove the remaining ethanol from the channels. The Tygon 
tubing (Tube Tygon s54HL.02X.06 500, Andwin Scientific) and metal couplers were 
autoclaved (Hirmaya HMC HV-85L). Then, metal couplers were attached to the inlet 
ports prior to sample loading into the microfluidic devices. Before usage, the media and 
PBS were warmed in a 37 °C water bath. Finally, 1000–10 000 cells/mL were loaded into 
the device using a 100 μL Hamilton syringe (Hamilton, 100 μl SYR, no. 84884). Both the 
inlet and the outlet channels of the cell culturing platforms were filled using prewarmed 
media with a height difference (h) to establish a flow in between inlet and outlet channels 
(Figure 3.11). The cells were collected at the chambers with single-cell resolution through 
the designed cell trapping mechanism. Upon examination of the cells in the microfluidic 
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cell culture platform on a table top microscope (Carl Zeiss, Primovert Model Trinocular 
Inverted Microscope), the device was placed into the incubator overnight to allow cell 
attachment to surface with an average medium flow rate of 4 μL/h. PBS-wetted tissue 
were placed inside the Becher glass, next to the chips to avoid media evaporation from 
the PDMS device (Figure 3.12).  
Figure 3.11. Schematic of cell loading procedure in a microfluidic PDMS device (cells 
are depicted as yellow circles) [83]. 
 
Figure 3.12. The PDMS devices loaded with MCF7 cells. 
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The gradient generator was tested initially with yellow and blue food dyes (Herco, 
no.156819593) through loading with gravity-driven flow. The image of this tested chip 
giving the mixed concentrations of the dyes can be found in the results section in Figure 
3.13. After, ensuring the chip is working both with simulations and experiments using 
food dyes, 1 mg/mL of fluorescein isothiocyanate (FITC; fluorescein5(6)-isothiocyanate, 
Sigma-Aldrich) solution in carbonate–bicarbonate buffer (lot no. RC233804, Thermo 
Scientific) was prepared with pH value 9. This solution was given from the first inlet, 
while introducing the carbonate–bicarbonate buffer without FITC via the second inlet 
using two syringes mounted on a syringe pump (New Era Pump Systems, NE-1000). The 
flow rate was initially set as 300 μL/h. Upon achieving a steady chemical gradient, the 
flow rate was reduced to 10 μL/h. 
After initial checks with dyes were completed, MCF7 breast cancer cells stably 
expressing RFP vector were grown inside 96-well plates (TPP). These cells were removed 
from the surface with Trypsin (3X, Pan Biotech) when their density reached 3.5 x 104 
cells/mL. An SDS concentration range of 0 % to 0.005 % gives the sensitivity and 
precision of the microfluidic gradient generator in Figure 3.13. Hence, the detached cells 
were cultured in Dulbecco’s phosphate buffered saline (PBS, Pan Biotech) supplemented 
with 0.005 %, 0.01 %, 0.025 %, 0.05 %, 0.075 % and 0.1 % sodium dodecyl sulfate (w/v) 
(SDS; MP Biomedicals, LLC, cat. No. 194831) and in PBS for 10 minutes inside the 
incubator (NUVE) to test the effective concentrations. Experiments were utilized in 
triplicate. Next, the well images were captured and the number of intact cells (excluding 
Trypan Blue solution; Sigma-Aldrich) were counted with a hemocytometer. SDS from 
one of the gradient generator inlets and PBS from the other one separately.  Cell viability 
in 96-well plate after exposure to SDS was plotted using Gradpad Prism based on the 
hemocytometer counting (Fig. 4.1.4). Thus, according to our experiment we proved the 
effective SDS concentrations as PBS supplemented with 0.005 %, 0.01 %, 0.025 %, 0.05 
%, 0.075 % and 0.1 % SDS (w/v).  
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After the preliminary tests for both the microfluidic cell culture chip and the 
gradient generator, first, MCF7-RFP cells were cultured and grown inside the six 
microchambers of the microfluidic cell culture array. Their microscopy images were taken 
with the inverted microscope for 3 days and their growth curve based on their fluorescent 
intensities was obtained in Gradpad Prism (Fig. 4.2.2 and Fig. 4.2.3). Second, the 
microfluidic gradient generator was integrated to the microfluidic cell culture platform 
through tubings (Fig. 4.3.3). Next, the gradient chip produced the SDS solution gradients 
for the concentrations of 0.005 %, 0.004 %, 0.003 %, 0.002 %, 0.001 % and 0 %, with 
PBS. Then, cells inside the chambers were exposed to SDS for 30 minutes with a flow 
rate of 10 μL/h. The images of cells before and after SDS exposure are depicted in the 
results section in Figure 4.3.4 along with their viability plots obtained in Gradpad Prism 
based on fluorescent intensities in Figure 4.5. 
 
Figure 3.13. a) Schematic view of the gradient generator and cell culture array [74]. 
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Figure 3.14. Integration of the gradient generator with the cell culture array using the 
connection tubing [74]. 
 
 
The chip in Figure 3.3 was tested experimentally for cell culturing with HepG2 
cells. Prior to cell loading into the microfluidic devices, cell culture platform, metal 
couplers and tips couplers were autoclaved (Hirmaya (HMC) HV-85L) and tips were 
connected to medium inlet and outlet ports. The medium was prewarmed at 37 °C water 
bath. HepG2 cells were centrifuged at 1800 rpm for 10 minutes in 15 mL falcons. Next, 
the supernatant was removed, and the pellet was completed to 1 mL including fresh 
DMEM with %10 FBS. Then, the cells were counted with hemocytometer and loaded into 
the device by a pipetman, connected to a blunt needle with a modified tip, with 
approximately 105 cells/mL. The chambers were filled with cells through the cell trapping 
mechanism in single cell resolution. The microfluidic platform was placed into an 
autoclaved glass beaker with tissues wetted with phosphate buffered saline (PBS, Sigma-
Aldrich) to avoid medium evaporation from the PDMS device. After microscopy 
inspection (Carl Zeiss, Primovert Model Trinocular Inverted Microscope) of the cells in 
the microfluidic cell culture platform, the device was transferred into the incubator 
overnight. 
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3.3 Fluorescent Imaging and Image Analysis 
                                
Images of the devices in Figure 3.12 tested with MCF7 cells, we acquired images 
with a 10X objective combining phase and DsRed fluorescent channels using a Carl Zeiss, 
Axio Observer Z1 motorized stage equipped with the AxioCam Mrc5 camera. The total 
fluorescent intensity of the cells within the microchambers were measured to quantify 
cellular growth using ImageJ software. To observe fluorescent intensity changes in the 
gradient generator, the imaging was done with green fluorescent filter with an exposure 
time of 400 ms. The composite image of the whole gradient generator was obtained via 
tiled images using Zen Pro microscopy software (Carl Zeiss). The fluorescent intensities 
obtained as 2.5D image (pseudo-3D image) through the same software. Upon FITC 
application to the chips resulting images were tiled together and their fluorescent 
intensities estimated via ZEN Pro 2 software (Zeiss). The images of the chambers after 
the SDS exposure were obtained using the DsRed fluorescent channel with an exposure 
time of 500 ms. The SDS effect was correlated with the fluorescent intensity values by 
measuring the total fluorescence intensity in the microchambers. 
During the growth of HepG2 cells inside the microfluidic cell culturing chip in Figure 
3.14, images of the individual chambers in the device were obtained using 10X objective 
and a Carl Zeiss, Axio Observer Z1 motorized stage equipped with the AxioCam Mrc5 
camera. Cell images were captured using 12.5 ms exposure under transparent light. After 
imaging, cells with and without pseupodium were counted.  
Upon introducing the cells into microchambers in the cell culturing chips, cells 
attached to the glass surface of the microfluidic chip overnight. Upon cell attachment due 
to the height difference between the inlet tip and outlet tips of the devices, gravity-driven 
medium flow fed the cells inside the microchambers. Cell growth was captured for 6, 18, 
48 and 72 hours using both phase and red fluorescent channels. Obtained images were 
quantified to determine the growth of the cells in the microfluidic cell culture array. With 
Gradpad Prism software, using the measured raw fluorescent intensities of the 
microchambers, intensity versus time plots were created for 6, 18, 48 and 72 hours.  
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The obtained chip images were used as a dataset and adaptive thresholding was 
performed to several images of the chips using Matlab. For cell counting Hough transform 
was applied, isolating features of a shape within an image. Since it needs target features 
to be specified in some parametric form, the typical Hough transform is generally used 
for detecting regular curves such as lines and circles for this case [84]. By defining cell 
nucleus in DAPI images as circle, cells were detected and counted directly from the 
images. For this the Hough transform algorithm was set to detect circles and draw a line 
around circles within the range of minimum radius 10 µm and maximum radius of 50 µm. 
Also, it was arranged to give the number of lines that are drawn to get the cell count 
information.                  
                          
3.4 Flow Cytometry (FACS) and Analysis 
         
In preliminary tests using IVFs, flowcytometry experiments were performed using 
the BD LSR Fortessa FACS analyzer (BD Biosciences, Franklin Lakes, NJ, USA). For 
high throughput, cell number was arranged to 2.5 x 105 cells/mL. Cells were kept inside 
IVF for 15 minutes. One sample group was exposed to PBS and stained with PI, while 
the other samples were exposed to IVFs (Dextrose, NaCl, Ringer) and stained with PI. 
The intact cells were determined according to their forward scatter (cell size) versus side 
scatter (cell granularity) profiles using blue (488 nm) excitation laser. The data was 
examined using the FlowJo v10 software (TreeStar, Inc., OR, USA). Double cell 
discrimination was done by plotting the height against the area for forward scatter. While 
double cells have roughly the same height with single cells, they have double the area 
values of single cells. Thus, we identified and excluded double cells based on 
disproportions between height and area [85]. Then, we separated live cells from debris 
and dead cells by gating on the area values of cells for forwards scatter versus side scatter 
plots. Events found at the bottom left corner of the density plots in gating were excluded 
to separate debris and dead cells with lower level of forward scatter [86] [87]. 
 
 
 
32 
 
 
 
 
 
 
 
Chapter 4 
 
RESULTS AND DISCUSSION  
 
4.1 Cell culture in conventional growth environment 
 
• U937 monocytes (the human myeloid leukemia) cell line 
(ATCC®CRL-1593.2™) 
 
U937 monocytes that were used for obtaining macrophages via differentiation through 
PMA were grown for viability confirmation using a 96-well plate. Cells were counted 
with a hemocytometer for 3 days in triplicates. The resulting graph plotted in Gradpad 
Prism using cell numbers per day can be seen in Figure 4.1.1 
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Figure 4.1.1. The plot for the growth of U937 monocytes in 96-well plates. The points on 
the growth line depicts the average value for cell growth and standard deviation of the 
growth. 
 
• U937 macrophages 
Upon differentiation of U937 monocytes into macrophages in petri dishes with 21 cm2 
growth area, macrophages were grown and ready to be used on day 5. The image of grown 
macrophages inside petri dishes can be seen in Figure 4.1.2 
Figure 4.1.2. The plot for the growth of U937 macrophages in 96-well plates.  
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• MCF7 human breast adenocarcinoma cell line (ATCC® HTB-22™) 
 
MCF7 cells that were being used in microfluidic devices were also cultured inside 
conventional platforms for validation of growth with a 96-well plate [88]. Cell counting 
was established with a hemocytometer for 3 days in triplicates.  
 
Figure 4.1.3. The plot for the growth of MCF7 cells in 96-well plates. The points on the 
growth line depicts the average value for cell growth and standard deviation of the growth 
[74]. 
 
From the testing of MCF7-RFP cells in PBS solutions with 0.005 %, 0.01 %, 0.025 
%, 0.05 %, 0.075 % and 0.1 % SDS (w/v) inside 96-well plates with hemocytometer-
based counting of intact cells a viability graph demonstrating the number of live cells 
versus SDS concentration was obtained (Fig. 4.1.4). This graph displays a correlation 
between the cell viability and SDS concentrations. According to Figure 4.1.4. cell 
viability goes down as the concentration of SDS in PBS solutions increases. As a 
consequence, the SDS concentrations in the range of 0 % to 0.005 % was confirmed to 
provide the sensitivity and accuracy of our microfluidic concentration generator. 
MCF7 
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Figure 4.1.4. Cell viability plot for MCF7 cells upon exposure to SDS in 96-well plate. 
and then exposed to SDS for 10 min in the incubator. The bars represent the average 
number of live cells shown with their standard deviations [74]. 
 
• HepG2 human liver hepatocellular carcinoma epithelial cell line (ATCC®HB-
8065™)  
 
HepG2 cells were grown inside a 96-well plate in addition to microfluidic platforms 
for the validation of cell growth. Upon daily cell counting with hemocytometer in 
triplicates the graph in Figure 4.1.4 was acquired using Gradpad Prism. 
Figure 4.1.5. The plot for the growth of HepG2 cells in 96 well plates. The points on the 
growth line depicts the average value for cell growth. 
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Growth of the hepatocellular carcinoma cell line was also observed at population-
level using petri dish with 21 cm2 growth area. Figure 4.1.6 is the image of hepatocellular 
cells overnight inside the petri dish taken with inverted microscope. For the investigation 
of cell heterogeneity, the number of cells that grow pseupodium and the number of cells 
that did not have pseupodium were plotted based on single-cell level analysis in Figure 
4.1.7. 
Figure 4.1.6. Microscopy image of HepG2 cells in tissue culture petri dish overnight at 
37 °C. The areas with pseupodium are denoted with black arrows [75]. 
 
Figure 4.1.7. Plot of liver cancer cells in the batch culture with and without pseupodium 
based on single-cell analysis [75]. 
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• U87 human brain glioblastoma epithelial cell line (ATCC® HTB-14™) 
 
Prior to their usage in co-culture platforms, U87 cell were cultured in a 96-well plate 
for growth confirmation. After counting cells daily with a hemocytometer in triplicates 
the graph in Figure 4.1.8 was acquired using Gradpad Prism. 
Figure 4.1.8 The growth of U87 cells in 96 well plates 
 
4.2. Cell culture in the artificial microfluidic platforms 
 
After growing cells inside conventional platforms, cells were cultured in PDMS based 
microfluidic platforms. 
 
• U937 macrophages 
 
Grown macrophages were removed from the petri dishes using Trypsin solution (3X).  
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• MCF7 human breast adenocarcinoma cell line (ATCC® HTB-22™) 
 
After transferring MCF7 cells into the microfluidic cell culturing platform in Figure 
3.13b, the cells were incubated overnight for cells attachment to the glass surface. Next, 
upon the adherence of cells to the surface, gravity-driven medium flow fed the cells inside 
the microfluidic chip. Images of grown cells inside the culturing chambers were captured 
with an inverted fluorescent microscope using phase and red fluorescent channels for 6, 
18, 48 and 72 hours (Fig. 4.2.1) [89]. The microscopy images were quantified measured 
raw fluorescent intensities of the microfluidic culturing chambers obtained with Image J 
for 6, 18, 48 and 72 hours in order to determine the growth rate of the cells inside the 
platforms (Fig. 4.2.2). Additionally, image processing was performed on the fluorescent 
microscopy images of Hoechst stained MCF7 cells to be able to modify images for further 
investigations and to be able to interpret experiment results accurately. Figure 4.2.3 
represents the fluorescent microscopy images of the stained MCF7 cells taken with DAPI 
channel before and after image processing in MATLAB. Also, as an alternative to 
hemocytometer, a Hough Transform algorithm for circles was offered for counting cell 
automatically from fluorescent microscopy images [90]. Cells were detected with the 
definition of cell nucleus in DAPI images as a circle and circle boundaries with a radius 
range from 10 to 50 using Hough Transform (Fig. 4.2.3.c). Finally, hemocytometry based 
cell counting was compared with automated cell counting via Hough Transform for circle 
boundaries and the results were plotted with a graph in Figure 4.2.4 [91].  
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Figure 4.2.1. Cellular growth of MCF7 cells inside the microfluidic culturing chambers 
[74]. 
 
 
Figure 4.2.2. The plot demonstrating the cell growth inside the microfluidic chambers in 
terms of raw fluorescent intensities. Points depict the average raw fluorescent intensity 
density measurement of three different microchambers. Error bars represent the standard 
deviation [74]. 
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Figure 4.2.3. The DAPI image of MCF7 cells inside a cell culturing chamber a) before 
and b) after Hough Transform and c) Adaptive Thresholding, respectively. 
 
Figure 4.2.4. Cell counting with hemocytometer (1) vs. Hough Transform (2) for circle 
boundaries with radius range of [10,50]. 
 
According to analysis results of image processing, Circle Hough Transform could detect 
more cells compared to counting done with hemocytometer, thus, demonstrated itself as 
a more accurate alternative than hemocytometer for cell counting. However, this 
algorithm was used only in Hoechst stained MCF7 cell images inside the microfluidic 
chip. In order to prove that this algorithm is more effective then hemocytometer-based 
counting further tests with a large data bank existing of cell images inside the microfluidic 
devices should be used [92]. Also, even though the algorithm was successful for the 
images used, it requires cell staining. Instead, a K-means algorithm combined with Hough 
Transform could be developed as a future solution which could allow the knowledge of 
cell count from microscopy images without staining cells [91]. This can decrease photo-
bleaching and phototoxicity during the fluorescence imaging. 
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• HepG2 human liver hepatocellular carcinoma epithelial cell line (ATCC®HB-
8065™) 
 
 
HepG2 cells were grown inside the microfluidic platform depicted in Figure 4.2.5 at 
single-cell level overnight. Cell images inside the culturing chamber were taken for 
morphology analysis upon incubation of cells overnight in the incubator (Figure 4.2.5.b). 
Figure 4.2.5. a) Microfluidic cell culturing platform for HepG2 cell morphology analysis. 
The chip consists of one inlet and one outlet for media flow. Cell loading hole was closed 
upon cell flow inside the culture chamber with a both ends closed metal pin. b) 
Microscopy image of the HepG2 cells inside the PDMS based microfluidic device 
overnight at 37 °C [75]. 
 
As expected, images of cells displayed cell heterogeneity [93]. Some cells 
developed cellular pseupodium while others remained circular. These cells either grew 
pseupodium in later phase of their inoculation or they never generated one. Figure 4.2.6 
demonstrates the count of single cells that grew pseupodium upon overnight incubation 
inside the microfluidic culturing chip. 
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Figure 4.2.6. Plot of liver cancer cells in the microfluidic cell culturing platform with and 
without pseupodium based on single-cell analysis [75]. 
 
Our preliminary result presents the morphological difference in between liver cancer 
cell lines grown inside the tissue-culture petri dish and in the microfluidic device. As it 
can be seen from Figure 4.2.5, the HepG2 cells did not generate any pseupodium when 
they were cultured in the PDMS based microfluidic device. Still, in conventional culturing 
platform, we observed cells with pseupodium upon overnight incubation (Fig. 4.1.5). 
When we quantified the microscopy images of these two culturing platforms, two graphs 
showing the number of cells with and without pseupodium in our culturing platforms were 
obtained (Fig. 4.1.6, Fig. 4.2.6). These plots confirmed our observations quantitatively 
based on single-cell analysis data. The outcomes of this research are backing Xiaohui et 
al. who similarly deduced that growth of live liver cancer cells is less feasible on silicon 
wafer upon investigation of liver cells under scanning probe acoustic microscope 
(SPAM) [94]. When the cells did not develop pseupodium inside our microfluidic device, 
they could not adhere to the surface of the glass and grow. They remained alive only for 
a few days with the spherical morphology. Additionally, they formed cellular clusters. 
Therefore, we stained these clusters with Hoechst and PI since they are commonly used 
dyes for cell-based research for the separation of live and dead cells [95] [96] [97]. 
According to our examination, most of the cells were dead. In order to develop better 
immune therapies or molecularly targeted treatments it is important to increase our 
knowledge of the variations in the microenvironment and the dynamic relation between 
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the microenvironment and tumor ecosystem [98].Consequently, researchers must be 
careful about the restraints of microfluidic technologies when these devices are being 
developed. Because, not carrying a cautious investigation about the limitations of the 
microfluidic platforms might mislead us into contemplating about on-chip liver cancer 
spheroids with PDMS based microfluidic chip on a glass surface. 
 
4.3 Cell culture and gradient generator using microfluidic platforms 
 
Starting with the growth of MCF7 cells inside the microfluidic platforms of our 
cell culture device, we investigated the effects of chemical concentrations to these cells. 
For this study, we decided to develop a gradient generator chip to supply gradients of 
chemicals into our microfluidic cell culturing device through tubings (Figure 3.13). Usage 
of microfluidic gradient generator for medical research has become common since it 
provides researchers the tools to examine gradient-driven mechanisms that are essential 
for important biological processes at a cellular level [99]. In batch culture, sensitive flow 
concentrations and blood flow cannot be modelled and tested. In addition to generating 
mixtures of chemicals, our microfluidic gradient generator allows cells to be examined in 
flow mimicking in vivo cell environment which is an advantage of advanced cell culturing 
platforms while this is a drag for the conventional culturing platforms [38] [100].  
The gradient chip platform allows the dilution of a chemical compound (Drug A) 
with PBS or the mixture of two different chemical agents (Drug A and Drug B) (Figure 
3.13). Prior to experimenting with the cell culture device, we tested the gradient generator 
with dyes for performance check using blue and yellow food dyes. We supplied these 
dyes to the devices through tubings with a gravity-driven flow. Figure 4.3.1 shows the 
outcome of experiments with each outlet port giving the specific concentration of the dye 
mixture. 
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Figure 4.3.1. Images of the microfluidic gradient generator after testing with the blue and 
yellow food dyes [74]. 
 
Next, FITC solution was fed through the first inlet as explained in the methods 
section. In Figure 4.3.2 represents the image of the microfluidic gradient generator with 
the FITC dye. The light intensity increased linearly from left (0% FITC) to right (100% 
FITC) as shown in Figure 4.3.2c. 
 
Figure 4.3.2. The microfluidic gradient generator with the FITC dye. (a) The tiled image 
of the gradient generator under steady-state flow (10 μL/h). (b) The diffusion of FITC and 
non-fluorescent buffer solutions in the microfluidic channel. Two solutions completely 
diffused together using a flow rate of 300 μL/h before bifurcation to produce 50 % FITC 
concentration. (c) The normalized 2.5D fluorescent intensity map of the gradient 
generator generated by ZEN 2 microscope software (Zeiss). (d) The gray value intensity 
alters along the yellow line illustrated in (a) show the stable distribution of FITC dye 
concentration in the concentration gradient generator [74]. 
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After performing initial assays with dyes, first, we waited for our MCF7 cells to grow in 
the six microchambers of our microfluidic cell culture array.  Then, we integrated the 
microfluidic gradient generator to the microfluidic cell culture platform through tubings 
(Figure 4.3.3). As a drug representative we delivered SDS solution to the gradient 
generator for acquiring the following concentrations, 0.005 %, 0.004 %, 0.003 %, 0.002 
%, 0.001 % and 0 %, with PBS given from the other inlet. Figure 4.3.4 demonstrates the 
cells before and after SDS exposure. We quantified these images according to intensities 
to obtain the correlating graph in Figure 4.3.5. Thus, we presented the SDS concentration-
dependent cell death in the microchambers. 
Figure 4.3.3. The image of the connected microfluidic cell culturing chip and gradient 
generator. 
 
Figure 4.3.4. SDS exposure in the microfluidic platform. The images present the change 
in fluorescent intensity for pre- and post-SDS exposure for 0, 0.001%, 0,002%, 0.003%, 
0.004%, and 0.005% SDS (wt/vol) [74]. 
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Figure 4.3.5. Raw fluorescent intensity densities of cells before and after SDS exposure 
in the microfluidic platform. The raw fluorescent intensity density prior to SDS exposure 
is illustrated with triangles. Squares show the fluorescent intensity densities post-SDS 
exposure [74]. 
 
The cell culture chip and the gradient generator chip introduced above can also be 
used separately from each other for different purposes. In the cell culture device with 6 
independent platforms, six different cell types can be grown at the same time while 6 
different concentrations of a chemical are being supplement to them via the gradient 
generator. Moreover, these controlled microenvironments can be observed with 
microscope thus allowing automated quantification of cell images. 
Here, we created a microfluidic platform with relatively simple fabrication and 
operation concerns compared to previously reported devices [Table 4.1]. Our chips can 
be utilized for culturing cells, generating gradients of a chemical and inducing chemical 
stress into grown cells in their microchambers. Furthermore, because of their simplicities, 
these microfluidic devices minimize experimental deviations and accomplishes practical 
automation. 
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Application Parallelization (chambers 
or wells) 
Automation Sensor 
integration 
Cell 
culture 
a. 
Cancer 
Cells 
384 [39], 96 
[101,[102], [103], [104]] 
64 [105], 24 [106,107,108], 
16 [109], 12 [45,110], 1 
[111,112,113] 
Data acquisition 
Fluid handling 
Environmental 
control 
Pressure 
sensor 
pH sensor 
Thermal 
sensor 
b. Stem 
Cells 
96 [114,115], 75 [116], 10 
[117], 6 [50], 3 [60], 1 
[112,118,119] 
Data acquisition 
Fluid handling 
Environmental 
control 
Thermal 
sensor 
pH sensor 
Pressure 
sensor 
c. 
Organ-
on-chip 
6 [120,121], 4 [122], 2 [123], 
1 
[124,125,[126], [127], [128],
129] 
Data acquisition 
Environmental 
control 
Fluid handling 
Fiber Optic 
sensors (O2) 
Temperature 
sensor & 
controller 
pH, DO, 
CO2sensor 
d. Body-
on-chip 
2 [130], 1 [131] 
Data acquisition 
Fluid handling 
Optical 
sensors 
e. other 
cells 
96 [132], 6 [133], 3 [62], 2 
[134] 
Data acquisition 
fluid Handling 
Environmental 
control 
Pressure 
sensor 
pH sensor 
Thermal 
sensor 
Drug 
screening 
 
32 [135] 8 [136], 4 
[137,138], 5 [139], 7 [108], 2 
[129], 1 [[140], [141], [142]] 
Data acquisition 
fluid Handling, 
motion tracking 
system, Image 
acquisition 
– 
Cryoprese
rvation of 
cells 
 96 [143], 1 [144] Data analysis – 
Table 4.1. Examples of microfluidic devices used for specific applications at different 
parallelization, automation and sensor integration levels [36]. 
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Within our knowledge, pure cell cultures were grown in vitro firstly more than 
100 years ago [145]. Hung et al introduced the first continuous perfusion microfluidic cell 
culture array to grow and monitor cells for long periods of time in 2004 [146]. Today, 
researchers are still producing novel tools to acquire more realistic physiochemical 
growth conditions for the cells, and automated quantification methods for their analysis 
[150-153]. Our technique supplies a simple and cost-effective way for cell culturing and 
economical way to culture cells and to add a gradient of a chemical into these cells when 
they were close to their natural microenvironment due to the small scale of the 
microchambers. Also, all our presented microdevices were compatible for gravity-based 
and syringe pump-produced flows. Cell mediums could be given through gravity-based 
continuous flow. Thus, thank to this flow, syringe-pump-free assays could be performed 
and transferred to the incubator easily. Therefore, our microfluidic chips might be suitable 
for most of research and clinical laboratories. Additionally, microfluidic concentration 
gradient generators have made an important contribution to biological operations for 
quantitative researches of chemotaxis, growth factor experiments and migration studies 
[153].  
We designed a SDS concentration gradient utilizing a Christmas tree type gradient 
generator, created by Jeon et al in 2000 [154]. This gradient generator has been studied 
broadly; Toh et al stated its typical operating feaurures for gradient stabilization in an 
outstanding review article [155]. Hence, we targeted the utilization of this platform rather 
than its characterization in our experiments. As Beta and Bodenschatz reviewed, the most 
common use of this platform is in investigating cellular chemotaxis. Hence, it was 
convenient for single-cell research, which involved a well-controlled spatiotemporal 
microenvironment and short experiment time, such as following cellular responses to fast 
switches of chemical gradients [156]. As mentioned above, Hung et al demonstrated the 
utilization of a 2D concentration gradient that was very similar to our work, where they 
directly connected the cell culture microchambers to microchannels of the gradient mixer 
[152]. This study was one of the pioneering works that implemented by Jeon and co-
workers for high-throughput cell-based experiments. Nevertheless, our proposed gradient 
generator chip is more practical in terms of fabrication and operation. The future trend of 
these technologies would focus more on translational research for clinical applications, 
such as Berthier and co-workers' arrayed high-content chemotaxis assay for patient 
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diagnostics [157]. From a broader perspective, we anticipate that microfluidic platforms 
would be rapidly developed and modified for simple applications, high sensitivity, high 
accuracy and high throughput automation to achieve a noteworthy contribution to bench-
to-bedside researches. 
 
 
4.4 Integration of IV fluids using conventional growth environment 
 
Evey year, a large number of patients are treated with intravenous fluids (IVFs). 
Lately, scientists have been focusing on recent cell-based medication approaches in which 
IVFs are essential to a large extent. Accordingly, the effect of IVFs on patients has been 
examined in referring to critical care practice [158, 159, 160, 161, 162]. Most of the 
investigations on IVFs have addressed to disclosing their influence on treatment stability, 
compatibility and administration [163]. Until now, there have been minor quantitative in 
vitro studies concerning the effect of IVFs on cellular level (Table 4.4.1). In our study, 
leaning towards the cell-based strategies, we presented the responses of U937 monocytes, 
U937-differentiated macrophages, HepG2 liver cancer and MCF7 breast cancer cells 
when they were exposed to IVFs. 
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IVF Cell line Method Result Raised Question Ref. 
Hyperton
ic saline 
(HTS) 
Human colon 
cancer cells 
(LS174T), 
Human 
umbilical vein 
endothelial 
cells 
(HUVECS) 
In vitro: Flow 
cytometry, 
fluorescence 
microscopy 
HTS reduces 
adhesion molecule 
and laminin 
expression. 
HTS did not alter 
cell viability. 
How does 
hypertonic saline 
contribute 
metastasis? 
163 
Plasma-
activated 
lactated 
Ringer 
(PAL) 
Human 
pancreatic 
cancer cells 
(Capan-2, 
BxPC-2, 
AsPC-
1/CMV-Luc, 
MIA PaCa-2) 
In vitro: 
Microscopy, 
Absorbance. 
In vivo: Mouse 
model (BALB/c 
Slc-nu/nu mice) 
PAL induces 
apoptosis in 
pancreatic cancer 
cells 
Is PAL convenient 
to be used as a 
therapeutic for 
peritoneal 
metastasis? 
164 
      
Hyperton
ic saline 
(HTS) 
Brain 
endothelial 
cells (bEnd.3) 
In vitro: Flow 
cytometry, 
RNA-seq, 
Quantitative 
real-time 
polymerase 
chain reaction, 
western blot, 
enzyme-linked 
immunosorbent 
assay 
40 mmol/L NaCl 
HTS enhances cell 
viability and 
attenuates cell 
apoptosis. 
How do the levels 
of IL-1β and EGFR 
is correlated to the 
performance of 
HTS and 
apoptosis? 
 
165 
Hyperton
ic saline 
(HTS) 
HeLa cells In vitro: 
Biochemical 
analysis, 
hemocytometry
, microscopy 
Increasing NaCl 
concentration more 
than 130 mM 
decreases growth 
rate, increases 
protein levels, and 
cell volume. 
Ionic and osmotic 
effects of HTS in 
the metabolism of 
HeLa cells 
166 
Hyperton
ic 
sucrose 
(HTSu) 
Human 
leukemia 
cells(U937) 
In vitro: Percoll 
gradient, ion 
concentration 
measurement, 
microscopy 
U937 cells 
developed apoptosis 
thanks to regulatory 
volume increase in 
HTSu. 
Are U937 cells 
capable of being a 
model organism to 
study cellular 
volume regulation? 
167 
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IVF Cell line Method Result Raised Question Ref. 
Hyperton
ic D-
glucose 
(HTD-g) 
Human breast 
cancer cells 
(MCF7) 
In vitro: MTT 
assay, Comet 
assay, flow 
cytometry 
HTD-g reduces the 
viability, increases 
the apoptosis and 
DNA damage of the 
MCF7 cells 
Does HTD-g 
induce cytotoxic, 
genotoxic, and 
apoptotic effects in 
tumor cells? 
168 
Table 4.4.1. Comparison of in vitro studies for IVF. 
 
 
First, we quantified the number of live and dead cells using hemocytometry and 
fluorescent microscopy imaging data for the U937 monocytes, U937-derived 
macrophages, MCF7, and HepG2 cancer cell lines after incubating cells in IVFs for 15 
minutes. Upon 15-minute incubation, cell viability of the U937 monocyte cells 
significantly decreased in IVFs while they were preserved in PBS (Fig. 4.4.1a and Fig. 
4.4.1b). We evaluated the differences in the changes of surface area and cell nuclei based 
on the microscopy images of the U937 cells in IVFs and PBS (Fig. 4.4.1c, Fig.4.4.1d, Fig. 
4.4.2a). Next, we used flow cytometry to examine a larger number of cells to confirm 
single-cell analysis data obtained with hemocytometer and microscopy images [169]. We 
separated dead cells from live cells through PI staining [95]. We investigated cell 
morphologies via forward scatter and side scatter data (Fig. 4.4.2, Fig. 4.4.3, Tables 4.4 
and 4.5) [170]. Then, we performed the same experiments and analyses for U937-derived 
macrophages, MCF7, and HepG2 cancer cell lines as well in triplicates.   
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Figure 4.4.1. Plots and correlating microscopy images showing cell viability and cellular 
area of the U937 monocyte cells. a) Cell viability graph of U937 monocytes showing the 
number of cells after incubation in IVF, medium and PBS for 15 minutes. One-way 
ANOVA Tukey’s Multiple Comparison Test is applied, p < 0.05 is significant. b) Surface 
area measurements of the U937 monocytes presented upon IVF treatment, medium and 
PBS incubations for 15 minutes. One-way ANOVA Tukey’s Multiple Comparison Test 
is applied, p < 0.05 is significant. c) The phase images of the U937 monocytes are 
obtained by the inverted fluorescent microscope after 15 minutes incubation in PBS, 
Dextrose, Ringer and NaCl solutions with 12,5 ms exposure time. d) Fluorescence 
microscopy images of the DAPI stained U937 monocytes, exposure time: 300 ms. The 
scale bar shows 20 µm. Data are representative of three independent experiments and the 
values are expressed in mean ± s.d. 
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Figure 4.4.2. Nucleus size of the IVF-treated cell lines. a) U937 monocytes, b) U937-
differentiated macrophages, c) HepG2, d) MCF7 cells. Analysis of the nucleus size with 
mean and standard deviations after 15 minutes incubation in Dextrose, NaCl, Ringer and 
PBS. One-way ANOVA Tukey’s Multiple Comparison Test was performed, p < 0.05 is 
significant. Three independent experiments were performed. 
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Figure 4.4.3. Forward scatter (FCS) vs. side scatter (SSC) data are illustrated in the dot 
display mode, and the core population of the U937 cells is surrounded by a gate for 
confirming cell morphology changes in IVFs. (a) The U937 monocytes without staining 
with PI and incubation in IVFs. (b) U937 monocytes with PI staining and without 
incubation in IVFs. U937 monocytes with PI staining and 15 minutes incubation in (c) 
PBS, (d) Dextrose, (e) Ringer, (f) NaCl. 
 
Figure 4.4.4. Statistical t-test analysis for the U937 monocyte data obtained in S2 Figure, 
(a) Forward scatter, (b) Side Scatter. 
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After incubating in IVFs, viability of the U937-differentiated macrophages 
significantly decreased, and their cellular area increased in IVF solutions (Fig. 4.4.5). 
The alterations in the area of nucleus size and the results of the flow cytometry analyses 
can be found in Figures 4.4.2, Figure 4.4.6 and Figure 4.4.7. 
 
Figure 4.4.5. Plots and correlating microscopy images showing cell viability and cellular 
area of the U937-differentiated macrophages. a) Cell viability graph of the macrophages 
showing the number of live and dead cells after incubation in IVF, medium and PBS for 
15 minutes. One-way ANOVA Tukey’s Multiple Comparison Test is applied; p < 0.05 is 
significant. b) Surface area measurements of the macrophages presented upon IVF, 
medium and PBS incubations for 15 minutes. One-way ANOVA Tukey’s Multiple 
Comparison Test is applied; p < 0.05 is significant. c) The phase images of macrophages 
are taken by inverted fluorescent microscopy after 15-minute incubation in PBS, 
Dextrose, Ringer and NaCl with 12,5 ms exposure time. d) Fluorescence microscopy 
images of the DAPI stained U937-differentiated macrophages, exposure time: 300 ms. 
The scale bar shows 20 µm. Data are representative of three independent experiments and 
the values are expressed in mean ± s.d. 
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Figure 4.4.6. Forward scatter (FCS) vs. side scatter (SSC) data are depicted in the dot 
display mode, and the core population of the U937-differentiated macrophages is 
surrounded by a gate for confirming cell morphology changes in IVF. (a) The U937-
differentiated macrophages without staining with PI and incubation in IV fluids. (b) U937 
monocytes with PI staining and without incubation in IVF. Macrophages with PI staining 
and 15 minutes incubation in PBS (c), in Dextrose (d), in Ringer (e), in NaCl (f). 
Figure 4.4.7. Statistical t-test analysis for the U937-differentiated macrophage data 
obtained in Figure S5, (a) Forward scatter, (b) Side Scatter. 
 
 
 
57 
 
Upon exposure to IVFs for 15 minutes, NaCl significantly decreased the viability 
of the HepG2 cells and their cellular area compared to other solutions (Figure 4.4.8). 
The analysis of the changes in the nucleus-size of HepG2 cells in IVFs and the flow 
cytometry data can be found in Figure 4.4.2, Figure 4.4.9 and Figure 4.4.10. 
 
 
Figure 4.4.8. Plots and correlating microscopy images showing cell viability and cellular 
area of the HepG2 cells. a) Cell viability graph of the macrophages showing the number 
of live and dead cells after incubation in IVF, medium and PBS for 15 minutes. One-way 
ANOVA Tukey’s Multiple Comparison Test is applied; p < 0.05 is significant. b) Surface 
area measurements of the HepG2 after IVF, medium and PBS incubations for 15 minutes. 
One-way ANOVA Tukey’s Multiple Comparison Test is applied; p < 0.05 is significant.  
c) The phase images of macrophages are taken by inverted fluorescent microscopy after 
15-minute incubation in PBS, Dextrose, Ringer and NaCl with 12,5 ms exposure time. d) 
Fluorescence microscopy images of the DAPI stained HepG2 cells, exposure time: 300 
ms. The scale bar shows 20 µm. Data are representative of three independent experiments 
and the values are expressed in mean ± s.d. 
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Figure 4.4.9. Forward scatter (FCS) vs. side scatter (SSC) data are depicted in the dot 
display mode, and the core population of the HepG2 cells is surrounded by a gate for 
confirming cell morphology changes in IV fluids. (a) The HepG2 cells without staining 
with PI and incubation in IV fluids. (b) The HepG2 cells with PI staining and without 
incubation in IV fluids. The HepG2 with PI staining and 15 minutes incubation in PBS 
(c), in Dextrose (d), in Ringer (e), in NaCl (f). 
 
Figure 4.4.10. Student’s t-test analysis for the HepG2 cells obtained in Figure S8, (a) 
Forward scatter, (b) Side Scatter comparison. 
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After incubating MCF7 cells in IVFS, Ringer solution significantly increased the 
viability of the MCF7 cells compared to other solutions; all IVFs increased the cellular 
area of the MCF7 cells (Figure 4.4.11). The plots for the analysis of the changes in the 
MCF7 cell nucleus-size with IVFs and the flow cytometry data can be found in Figure 
4.4.2, Figure 4.4.12 and Figure 4.4.13. 
 
 
Figure 4.4.11. Plots and correlating microscopy images showing cell viability and cellular 
area of MCF7 cells. a) Cell viability graph of the macrophages showing the number of 
live and dead cells after incubation in IVF, medium and PBS for 15 minutes. One-way 
ANOVA Tukey’s Multiple Comparison Test is applied; p < 0.05 is significant. b) Surface 
area measurements of the MCF7 presented upon IVF, medium and PBS incubations for 
15 minutes. One-way ANOVA Tukey’s Multiple Comparison Test is applied; p < 0.05 is 
significant. c) The phase images of macrophages are taken by inverted fluorescent 
microscopy after 15-minute incubation in PBS, Dextrose, Ringer and NaCl with 12,5 ms 
exposure time. d) Fluorescence microscopy images of the DAPI stained MCF7 cells, 
exposure time: 300 ms. The scale bar shows 20 µm. Data are representative of three 
independent experiments and the values are expressed in mean ± s.d. 
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Figure 4.4.12. Forward scatter (FCS) vs. side scatter (SSC) data are depicted in the dot 
display mode, and the core population of the MCF7 cells is surrounded by a gate for 
confirming cell morphology changes in IV fluids. (a) The MCF7 cells without staining 
with PI and incubation in IV fluids. (b) The MCF7 cells with PI staining and without 
incubation in IV fluids. The MCF7 with PI staining and 15 minutes incubation in PBS 
(c), in Dextrose (d), in Ringer (e), in NaCl (f). 
Figure 4.4.13. Statistical t-test analysis for the MCF7 cells obtained in Figure S11, (a) 
Forward scatter, (b) Side Scatter comparison. 
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According to the One-way ANOVA Tukey’s Multiple Comparison Test, we listed 
the response of U937 monocyte, U937-differentiated macrophage, HepG2, and MCF7 
cells in Table 4.4.2 and Table 4.4.3. Our single-cell analysis outcomes revealed that the 
viability of the immune cells decreased more than that of cancer cells when they were 
incubated in IVFs (Table 4.4.2). The statistical analysis of the forward and side scatter 
data obtained using flow cytometry can be found in Table 4.4.4 and Table 4.4.5. 
 
Viability Dextrose Ringer NaCl Medium 
U937 Monocyte ns *** *** ns 
U937-differentiated 
Macrophage 
*** ** *** ns 
HepG2 ns ns *** ns 
MCF7 ns ** ns ns 
Table 4.4.2. One-way ANOVA Tukey’s Multiple Comparison Test results for the   
viability of U937 monocytes, macrophages, HepG2, and MCF7 cells in IVF relative to 
PBS. p < 0.05 is significant. 
 
 
 
 
 
Table 4.4.3. One-way ANOVA Tukey’s Multiple Comparison Test results for the cellular 
area and nuclear area measurements of the U937 monocytes, macrophages, HepG2, and 
MCF7 cells in IVF relative to PBS. p < 0.05 is significant. 
 
 
 
 
 
 Dextrose Ringer NaCl 
Area 
measurements 
Surface  Nucleus Surface  Nucleus Surface  Nucleus 
U937 Monocyte *** * * ns *** * 
U937-
differentiated 
Macrophage 
* ** *** *** *** *** 
HepG2 *** ns *** ns ns * 
MCF7 ns ns *** * ns ns 
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Table 4.4.5. Student’s t-test results based on side scatter comparison using flow cytometry 
data. 
 
Among IVFs used in treatments, dextrose solution is one of the most frequently 
applied diluents in clinics. Nevertheless, new investigations have disclosed an increasing 
concern over the safety of dextrose solution [171]. This is because dextrose is a form of 
glucose, which might change cellular capability to maintain ion and water balance, 
intracellular homeostasis. Hence, dextrose solution might splinter the plasma membrane, 
leading to cytoplasm leakage into the extracellular environment [172]. Our outcomes 
demonstrated that dextrose solution decreased the viability of the U937-differentiated 
macrophage cells (Fig. 4.4.5a and Table 4.4.2). Cellular and nuclear area of macrophage 
cells increased in dextrose solution, but it did not significantly influence MCF7 cells (Fig. 
4.4.5b, Fig. 4.4.6, Fig. 4.4.7, Fig. 4.4.11b and Table 4.4.3).  
The NaCl diluent is another fundamental diluent in clinics; still, it has been 
proclaimed that it might cause hyperchloremia, metabolic acidosis, acute kidney injury 
Cell Lines Dextrose Ringer NaCl 
Monocyte *** (p< 0.0001) *** (p< 0.0001) *** (p< 0.0001) 
Macrophage *** (p< 0.0001) *** (p< 0.0001) *** (p< 0.0001) 
HepG2 *** (p< 0.0001) *** (p< 0.0001) ** (p=0.0013) 
MCF7 *** (p< 0.0001) *** (p< 0.0001) *** (p< 0.0001) 
Table 4.4.4. Student’s t-test results based on forward scatter 
comparison using flow cytometry data. 
 
 
    
  Cell Lines Dextrose Ringer NaCl 
Monocyte *** (p< 0.0001) *** (p< 0.0001) *** (p< 0.0001) 
Macrophage *** (p< 0.0001) ns (p=0.2188) *** (p< 0.0001) 
HepG2 *** (p< 0.0001) *** (p< 0.0001) *** (p< 0.0001) 
MCF7 ns (p<0.6259) *** (p< 0.0001) *** (p< 0.0001) 
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and renal vasoconstriction [171]. Thus, our results of the viability experiments with 
diminishing number of cells after exposure to NaCl solution, with the exclusion of MCF7 
cells, are backed due to the NaCl solution making the medium hypertonic [173]. Our 
outcomes showed that NaCl significantly decreased viability of U937 monocytes, 
macrophages and HepG2 cells (Fig. 4.4.1a, Fig. 4.4.5a, Fig. 4.4.8a and Table 4.2). 
Moreover, neither the cellular nor the nuclear areas of the MCF7 cells were altered in 
NaCl diluent, whereas others were affected (Fig. 4.4.1b, Fig. 4.4.2, Fig. 4.4.5b, Fig. 4.4.8b 
4.4.11b and Table 4.4.3).   
As reported by intensive care units, in spite of NaCl and dextrose being the 
fundamental crystalloid fluids for revival, the usage of lactated Ringer has elevated lately 
[174][175][176]. Dr. Brown and co-worker’s argument concerning the results of the 
treatment diluent suggested balanced crystalloids like lactated Ringer solution since their 
chemical composition is harmless for the acid-base status and organ function of a patient 
[171][177]. In our research, the viability of immune related cells, U937 monocytes and 
U937-differentiated macrophages, diminished while the viability of breast cancer cells 
elevated in Ringer solution (Fig. 4.4.1a, Fig. 4.4.5a, Fig. 4.4.8a, Fig. 4.4.11a and Table 
4.2). Cellular and nuclear areas of the cells expanded in the Ringer solution, with the 
exclusion of U937 monocyte cells whose cellular size became smaller, and nuclear size 
was not significantly changed (Fig. 4.4.1b, Fig. 4.4.2, Fig. 4.4.5b, Fig. 4.4.8b 4.4.11b and 
Table 4.4.3).   
In this investigation, we detected that IVFs lowered the viability of immune cells 
more than cancer cells (Fig. 4.4.1a, Fig. 4.4.5a, Fig. 4.4.8a and Table 4.2). Also, we 
showed that IVFs alter cellular or nuclear areas of the cells (Fig. 4.4.1b, Fig. 4.4.2, Fig. 
4.4.5b, Fig. 4.4.8b 4.4.11b and Table 4.4.3). Kadota et al. expressed that the nuclear 
diameter of the cells is one of the independent predictive elements for bad reactions when 
they conducted extensive pathological analysis in lung squamous cell carcinoma [178]. 
Cell morphology and surface are important biomechanical features for main cellular 
actions such as adhesion, spread and migration [179][180]. Based on our results, IVF 
might also cause to diversity of nuclear diameter when patients are given medication with 
IVFs. Especially, for the lactated Ringer diluent, a previous research conducted by 
Bonuccelli et al., in which MCF7 cells were used in a co-culture environment, 
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demonstrated a risk of advanced metastasis in cancer patients [175]. Hence, the utility of 
IVFs should be investigated to dispose of the spreading doubt over its safety and benefits.  
Distinctly, in this research, we examined the surface areas of cells and their nuclei 
performing image analysis on microscopy images as well [181]. Still, the number of cells 
was relatively low for image analysis; thus, we performed flow cytometry analysis as 
mentioned above (Fig. 4.4.3, Fig. 4.4.4, Fig. 4.4.6, Fig. 4.4.7, Fig. 4.4., Fig. 4.4.10, Fig. 
4.4.12, Fig. 4.4.13, Table 4.4.4 and Table 4.4.5). However, our work has an important 
limitation which is that this study shows in vitro behavior of cell lines with IVFs that do 
not represent completely the interactions in the human body when the medicine is given 
with IVFs.  
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Chapter 5  
 
CONCLUSION AND FUTURE WORK 
 
In this thesis, novel microfluidic cell culturing platforms and a microfluidic 
gradient generator were designed, fabricated and tested using mammalian cancer and 
immune system cell lines after initial testing for feasibility with food dyes. First, a 
microfluidic cell culturing chip and a microfluidic gradient generator allowing the analysis 
of cells in flow, and microscopy imaging was enabled thanks to the transparency of the 
PDMS mold. These devices were tested with MCF7 cells and different concentrations of 
SDS as a drug representative providing a way to evaluate the efficacy of a drug on a single 
type or different types of cells through microfluidic platforms. The cell culturing chip and 
the microfluidic gradient generator can be utilized for personalized medicine through the 
application of different concentrations of a drug with the gradient generator and 
examination of the response of cells to the stimuli inside the culturing chambers. However, 
there were problems in the experiments due to bubble formation during cell loading. 
Hence, a new and plain microfluidic cell culturing chip was designed, fabricated and used 
to investigate the behavior of HepG2 liver cancer cells. To this device, as distinct from 
the previous devices, an inlet tip and an outlet tip for medium exchange were inserted 
providing stable fluid flow through height differences between tips. HepG2 cells were 
grown both at population-level using batch culture and at single-cell level using our 
microfluidic-microscopy system. After overnight incubation of cells, some of the cells 
inside the petridish remained circular while other cells generated pseupodium. However, 
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in our microfluidic device we did not observe any pseupodium. Cells without pseupodium 
could not attach to the surface of the glass and grow. Our experiment demonstrated the 
difference in the behavior of liver cells in our microfluidic device compared to their 
behavior in a macroscopic petridish. This variation in the action of liver cells involving 
the presence or absence of pseupodium growth is caused by cell heterogeneity. This study 
showed that a better understanding of liver cell heterogeneity is needed. In order to 
achieve this goal, new standardized microdevices can be developed allowing single-cell 
analysis with high throughput and high content analysis. In this way, new knowledge 
about the behaviors of liver cells and their heterogeneity in response to their 
microenvironments can be obtained and novel liver cancer treatments can be developed. 
After examining a single type of cell per a microfluidic platform, a microfluidic 
co-culturing platform was designed, fabricated and tested with U87 brain cancer cells with 
U937 macrophages differentiated from U937 monocytes. This chip, as different from our 
previous devices, was used to investigate the invasiveness of the U87 cells. The 
preliminary results that were obtained showed that U937 macrophages were moving 
towards U87 cells. 
Shifting focus to a better understanding of cell behavior, the influences of IVF on 
U937 monocytes, U937-differentiated macrophages, HepG2, and MCF7 cancer cells were 
examined in vitro by exposing the cells to IVF for 15 minutes since patients are given 
IVFs for 15 minutes. This inquiry revealed that viability of the monocytes and 
macrophages significantly decreased compared to those of breast and liver cancer cells. 
Additionally, differences in the nuclear and cellular area of cells were brought in with 
IVF. Our conclusions should be elucidated carefully because our results exhibit in vitro 
behavior with IVF in cell lines that do not represent exactly the interactions in the human 
body when medication is delivered via IVF. Still, our work demonstrates the urgent need 
for more precise investigation of IVF at high resolution and more physiologically relevant 
human body mimicking models. As future work, 3D organs-on-a-chip studies might be 
conducted which might provide a better understanding of biokinetics, signaling between 
cells and clinical insights [37]. Currently, organotypic culture studies are also in their 
infancy and there is an urgent need for their improvement to achieve in vivo likeness with 
a better practical usage in clinical studies [38]. 
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Finally, it was noticed that the cell growth rates in our microfluidic cell cultures 
are several orders of magnitude less than those of the tested conventional cell cultures. 
This aspect has enormous potential for further researching these types of microfluidic cell 
cultures, or for studies which deal with the effects of physical parameters such as shear 
flow and geometry on cell growth, signaling, and other vital cellular interactions.
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